Alectinib-induced Immune Hemolytic Anemia in a Patient with Lung Adenocarcinoma

Drug-induced immune hemolytic anemia (DIIHA) is a rare condition with an increasing incidence associated with the frequent use of certain drugs. An 85-year-old woman with lung adenocarcinoma prescribed alectinib complained of dyspnea on exertion at our hospital. Based on her laboratory tests results...

Descripción completa

Detalles Bibliográficos
Autores principales: Okumoto, Joe, Sakamoto, Shinjiro, Masuda, Takeshi, Yamaguchi, Kakuhiro, Horimasu, Yasushi, Miyamoto, Shintaro, Nakashima, Taku, Iwamoto, Hiroshi, Fukushima, Noriyasu, Fujitaka, Kazunori, Hamada, Hironobu, Hattori, Noboru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946499/
https://www.ncbi.nlm.nih.gov/pubmed/32999219
http://dx.doi.org/10.2169/internalmedicine.4241-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946499/
https://www.ncbi.nlm.nih.gov/pubmed/32999219
http://dx.doi.org/10.2169/internalmedicine.4241-19

Ejemplares similares